Shukla Sath - Insider Transactions
Insider Type
corporate
Companies
1
Average
34,406
Total Txns
8
Long-Term
Annual Transaction Insights
Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
---|---|---|---|---|---|---|
2024 | 0 | 5 | -5 | 0.00 | 154,086.88 | -154,086.88 |
2025 | 0 | 3 | -3 | 0.00 | 121,159.74 | -121,159.74 |
Total: | 0 | 8 | 8 | 0.00 | 275,246.62 | -275,246.62 |
Transactions
Company | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Spero Therapeutics, Inc. Common Stock US84833T1034 |
0.78 USD |
6,139 Sold |
4,788 USD |
03/02/2025 | 05/02/2025 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
0.78 USD |
42,786 Sold |
33,373 USD |
03/02/2025 | 05/02/2025 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
0.78 USD |
106,408 Sold |
82,998 USD |
03/02/2025 | 05/02/2025 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
1.35 USD |
2,757 Sold |
3,722 USD |
27/08/2024 | 27/08/2024 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
1.32 USD |
14,800 Sold |
19,536 USD |
02/08/2024 | 02/08/2024 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
1.31 USD |
17,641 Sold |
23,110 USD |
02/08/2024 | 05/08/2024 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
1.37 USD |
30,901 Sold |
42,334 USD |
01/02/2024 | 02/02/2024 |
Spero Therapeutics, Inc. Common Stock US84833T1034 |
1.45 USD |
45,093 Sold |
65,385 USD |
01/02/2024 | 05/02/2024 |